Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

REPH

Recro Pharma (REPH)

Recro Pharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:REPH
일자시간출처헤드라인심볼기업
2023/06/0705:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
2023/06/0305:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/2705:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2023/05/2306:11Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:REPHRecro Pharma Inc
2023/05/2005:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/2005:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/2005:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/2005:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/2005:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/2005:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/05/1906:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2023/05/1105:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2023/05/0405:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/04/0621:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPHRecro Pharma Inc
2023/03/2505:07Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:REPHRecro Pharma Inc
2023/03/2505:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2023/03/1320:40Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2023/03/0207:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
2023/03/0206:58Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
2023/03/0206:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REPHRecro Pharma Inc
2023/03/0206:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2023/02/1504:58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
2023/02/1023:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
2023/02/0307:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/01/2106:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/01/0606:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
2023/01/0606:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
2023/01/0406:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2022/12/2106:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
2022/12/1707:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REPHRecro Pharma Inc
 검색 관련기사 보기:NASDAQ:REPH